A STAT News article highlights new research lending insight into sudden cardia arrest, which kills more than 400,000 Americans every year. Eric Stecker, M.D., says less-immediate warning signs could be longstanding issues such as heart failure and diabetes. “Because the person had a heart attack two years ago, or they have a cardiomyopathy where their heart is weak, those can predispose to primary arrhythmias that can lead to death without a heart attack.”

In a The New York Times profile on the use of artificial intelligence implants to produce sounds that came close to matching the true voice of a patient with ALS, Melanie Fried-Oken, Ph.D., says financial incentives make it likelier that people with disabilities will become poor, putting access to cutting-edge implants even further out of their reach.

Longtime Wieden + Kennedy executive Jim Riswold died from complications from cancer. Riswold was diagnosed with leukemia in 2000 and treated by Brian Druker, M.D., at OHSU. In 2011, Druker and Riswold gave a TED Talk together, and remained friends. Druker says, “What was remarkable about Jim is that if you do a search on him, you realize he created all of the iconic Nike advertisements and he hung out with Michael Jordan and Charles Barkley and Tiger Woods, and he’d never sit around and say, ‘I was hanging out with Michael Jordan.’ He was just a regular guy with a great sense of humor.”

Longtime Wieden + Kennedy executive Jim Riswold died from complications from cancer. Riswold was diagnosed with leukemia in 2000 and treated by Brian Druker, M.D., at OHSU. In 2011, Druker and Riswold gave a TED Talk together, and remained friends. Druker says, “What was remarkable about Jim is that if you do a search on him, you realize he created all of the iconic Nike advertisements and he hung out with Michael Jordan and Charles Barkley and Tiger Woods, and he’d never sit around and say, ‘I was hanging out with Michael Jordan.’ He was just a regular guy with a great sense of humor.”

KOIN-TV highlights a groundbreaking technique being used at OHSU for osteoarthritis of the knee, a degenerative joint disease.

Continued coverage on an OHSU study that discovered potential impacts of poor air quality for patients undergoing in vitro fertilization treatment, or IVF. Molly Kornfield, M.D., says, "'Our hope is that this research informs preparedness measures that can ensure the best possible outcomes for our patients when we do face these serious air quality crises."

When considering when to get a booster, Fikadu Tafesse, Ph.D., suggests that people who are at high risk should talk with their doctors about the ideal interval between vaccines.

An OHSU study finds a benefit of white and pink noise on task performance among children and college-age young adults with ADHD. The study’s lead author, Joel Nigg, Ph.D., says, “While additional research is needed to translate the findings to clinical practices, these initial results should be seen as encouraging. Supportive interventions continue to be needed for ADHD, which affects millions of kids and adolescents around the world."

Mark Garzotto, M.D., shares insight on a study that investigated the effects of high-intensity interval training for men with prostate cancer. He says, “When clinicians see these patients, it is important to discuss modifiable factors including diet and lifestyle. Whenever possible I try to engage the patient’s partners in the conversation and discuss specific changes that are reasonable for them and re-visit these at every follow-up appointment."

A collaborative study between OHSU and the University of California San Francisco finds one shot of Therapeutic Interfering Particles, or TIPs, dramatically reduces levels of HIV in nonhuman primates. One of the study’s authors, Nancy Haigwood, Ph.D., says, “If TIPs can reduce HIV in people like it has in our nonhuman primate study, this technology could open the door to alternative approaches to HIV care and mean people won’t have to take medications for the rest of their lives. That is incredibly exciting."